Clinical Trials · NCT07265752
Tirzepatide for the Treatment of Cannabis Use Disorder
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 6
- Start date
- Jul 2026
- Locations
- See registry
- Primary endpoint
- Cue-Induced Craving